New daily pill aims to tame type 2 diabetes safely over the long haul
NCT ID NCT06010004
First seen Jun 30, 2026 · Last updated Jul 01, 2026 · Updated 1 time
Summary
This study tests the long-term safety of an experimental oral drug called orforglipron in adults with type 2 diabetes whose blood sugar is not well controlled by diet, exercise, or other diabetes pills. Participants take the drug once daily for about a year, and researchers monitor for side effects and changes in blood sugar levels. The goal is to see if orforglipron can be a safe, long-term treatment option.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
orforglipron (LY3502970)
What this could lead to
If successful, this could provide a new, convenient once-daily oral option for managing type 2 diabetes long-term.
What could go wrong
This is a safety-focused study, so effectiveness is not the primary goal. Side effects may emerge, and results may not apply to all diabetes patients.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE 2 DIABETES are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Abe Clinic
Ōita, 870-0039, Japan
-
Fujii Clinic
Ube, Yamaguchi, 755-0049, Japan
-
Fukuwa Clinic
Chuo-ku, Tokyo, 104-0031, Japan
-
Gibo Hepatology Clinic
Matsumoto, Nagano, 399-0036, Japan
-
Hachioji Diabetes Clinic
Hachioji-shi, Tokyo, 192-0083, Japan
-
Hasegawa Medical Clinic
Chitose, Hokkaido, 066-0032, Japan
-
Heishinkai Medical Group ToCROM Clinic
Shinjuku-ku, Tokyo, 160-0008, Japan
-
Heiwadai Hospital
Miyazaki, 880-0034, Japan
-
Jinnouchi Hospital
Kumamoto, 862-0976, Japan
-
Kanno Naika
Mitaka, Tokyo, 181-0013, Japan
-
Kansai Electric Power Hospital
Osaka, 553-0003, Japan
-
Kashiwa City Hospital
Kashiwa, Chiba, 277-0825, Japan
-
Kitada Clinic
Osaka, Osaka, 538-0044, Japan
-
Matsuda Clinic
Kobe, Hyōgo, 651-2135, Japan
-
Medical Corporation Heishinkai OCROM Clinic
Suita-shi, Osaka, 565-0853, Japan
-
Medical Corporation Tao Internal Medicine Clinic
Ube, Yamaguchi, 755-0047, Japan
-
Medical Corporation Yuga Tsuruma Kaneshiro Diabetes Clinic
Yamato-shi, Kanagawa, 242-0004, Japan
-
Mikannohana Clinic, Diabetes, Endocrinology and Metabolism
Matsuyama, Ehime, 790-0034, Japan
-
MinamiAkatsukaClinic
Mito, Ibaraki, 311-4153, Japan
-
Morinaga Ueno Clinic
Kumamoto, 860-0863, Japan
-
Nakakinen clinic
Naka, Ibaraki, 311-0113, Japan
-
Nakamoto Internal Medicine Clinic
Mito, Ibaraki, 310-0826, Japan
-
Nakayama Clinic
Nagoya, Aichi-ken, 456-0058, Japan
-
Nishiyamadou Keiwa Hospital
Naka, Ibaraki, 311-0133, Japan
-
OHAMA Diabetes Clinic
Kawaguchi, Saitama, 332-0015, Japan
-
Odori Diabetes
Sapporo, Hokkaido, 060-0001, Japan
-
Seiwa Clinic
Adachi-ku, Tokyo, 120-0011, Japan
-
Shinkashiwa Clinic
Kashiwa, Chiba, 277-0084, Japan
-
Shiraiwa Medical Clinic
Kashihara, Osaka, 582-0005, Japan
-
Shonan Takai Clinic
Kamakura, Kanagawa, 247-0055, Japan
-
Steel Memorial Yawata Hospital
Kitakyushu, Fukuoka, 805-8508, Japan
-
Sugiura Internal Medicine Clinic
Sōka, Saitama, 340-0015, Japan
-
Takai Internal Medicine Clinic
Kamakura-shi, Kanagawa, 247-0056, Japan
-
Tashiro Endocrinology Clinic
Fukuoka, 814-0153, Japan
-
Taya Clinic Koueikai Medical Corporation
Tsuchiura, Ibaraki, 300-0047, Japan
-
The Institute for Adult Disease, Asahi Life Foundation
Chuo-ku, Tokyo, 103-0002, Japan
-
Tokuyama Clinic
Mihama-ku,Chiba City, Chiba, 261-0004, Japan
-
Tokyo-Eki Center-building Clinic
Chuo-ku, Tokyo, 103-0027, Japan
-
Yokkaichi Diabetes Clinic
Yokkaichi, Mie-ken, 510-0829, Japan
-
Yokohama Minoru Clinic
Yokohama, Kanagawa, 232-0064, Japan